Onconetix (ONCO) Announces $2M Financing, $25M Equity Line of Credit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. META
5. LDOS
6. PLTR
7. CSCO
8. KTOS
9. QQQ
10. DT

Go back to Onconetix (ONCO) Announces $2M Financing, $25M Equity Line of Credit

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

October 3, 2024 9:05 AM EDT

CINCINATTI, Oh., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (Onconetix or the Company) (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development and commercialization of innovative solutions for oncology, today announced the signing and closing of a private placement of (i) 3,499 shares of the Companys Series C Convertible Preferred Stock, $0.00001 par value (the Series C Preferred Stock), and (ii) warrants (the Warrants) to acquire up to an aggregate of 591,856 additional shares of the Companys common stock, $0.00001 par value per share (the Common Stock), for aggregate gross proceeds of approximately $2.0 million.... More